RCM Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 36.80%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

R1 RCM Insider Trading History Chart

This chart shows the insider buying and selling history at R1 RCM by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M$0$200MTotal Insider BuyingTotal Insider Selling

R1 RCM Share Price & Price History

Current Price: $14.31
Price Change: Price Increase of +0.01 (0.07%)
As of 11/19/2024 09:00 PM ET

This chart shows the closing price history over time for RCM up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

SEC Filings (Institutional Ownership Changes) for R1 RCM (NASDAQ:RCM)

61.10% of R1 RCM stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCM by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$11MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$400M-$200M$0$200M$400MTotal InflowsTotal Outflows
R1 RCM logo
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.
Read More on R1 RCM

Today's Range

Now: $14.31
Low: $14.30
High: $14.32

50 Day Range

MA: $14.28
Low: $14.20
High: $14.31

52 Week Range

Now: $14.31
Low: $10.58
High: $14.32

Volume

13,784,800 shs

Average Volume

3,353,316 shs

Market Capitalization

$6.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.84

Who are the company insiders with the largest holdings of R1 RCM?

R1 RCM's top insider shareholders include:
  1. John M Sparby (President)
  2. Richard B Jr Evans (Insider)
  3. John B Henneman III (Director)
Learn More about top insider investors at R1 RCM.

Who are the major institutional investors of R1 RCM?

R1 RCM's top institutional shareholders include:
  1. Nomura Holdings Inc. — 0.00%
  2. LMR Partners LLP — 0.00%
  3. Group One Trading LLC — 0.00%
  4. Caption Management LLC — 0.00%
  5. Citadel Advisors LLC — 0.00%
  6. HAP Trading LLC — 0.00%
Learn More about top institutional investors of R1 RCM stock.

Which major investors are selling R1 RCM stock?

Within the previous quarter, RCM stock was sold by these institutional investors:
  1. Nomura Holdings Inc.
  2. LMR Partners LLP
  3. Caption Management LLC
  4. Group One Trading LLC
  5. BCK Capital Management LP
  6. HAP Trading LLC
  7. Wolverine Trading LLC
  8. Citadel Advisors LLC